Government Bodies

The global agenda of the EORTC to interact with competent regulatory bodies is a recognition for its abilities and knowledge in the field of cancer clinical research. It is being made possible due to its independence.

European Medicines Agency (EMA)
EORTC contributes to many EMA events by providing expertise in clinical research methodology. An EORTC statistician sits on the EMA Scientific Advisory Group (SAG). EMA is also a partner of the EORTC regulatory sciences meeting, known as Innovation for Biomarker and Cancer drug Development (IBCD)(link)

European Commission
EORTC interacts closely with varying EU Directorate-General departments (DGs) as needed, especially for implementing EU regulations

EU Calls for projects
The European Union supports projects with great public health value, providing funding that is not otherwise available. Over the years, EORTC has participated in numerous projects funded by the European Commission in various cancer and clinical research-related fields. We believe our participation in these programmes confirms EORTC’s position as a top-class, independent clinical research infrastructure.

  • Innovative Medicine Initiative (IMI): EORTC is a major participant in the Innovative Medicine Initiative (IMI), involved in seven funded projects and coordinating two of them: QuIC-ConCePT, an imaging program aiming to qualify and validate biomarkers and TRISTAN, developing imaging biomarkers as reliable methods for drug safety assessment.
  • Horizon 2020: EORTC is participating in various H2020 projects including MoTriColor, where we are supporting three molecularly-guided clinical trials in colorectal cancer patients.

Health Technology Assessment bodies
As a clinical research expert organisation, EORTC looks to establish areas of mutual understanding and concrete collaboration with national and international HTA bodies such as EUnetHTA.

National governments and agencies
On a case-by-case basis, EORTC directly interacts with governments, drug agencies or health ministries on specific projects, more general advice or implementing regulations.